查询词典 MD

"Histologic studies evaluating SLT have shown that, unlike argon laser trabeculoplasty, there is no scarring of the trabecular meshwork," write Shlomo Melamed, MD, and colleagues from the Goldschleger Eye Institute, Sheba Medical Center, in Tel Hashomer, Israel."Clinical results have shown the treatment to be effective and safe in patients with primary open-angle glaucoma and in patients treated previously with ALT."

Goldschleger眼科学校的Shlomo Melamed博士表示，评估SLT的组织学研究显示，小梁成型术与氩雷射不同的是，它不会造成小梁组织网结疤，临床的研究结果显示，对於开放性青光眼初期患者及之前以ALT治疗的患者而言，小梁成型术是有效且安全的治疗方式。

"Histologic studies evaluating SLT have shown that, unlike argon laser trabeculoplasty, there is no scarring of the trabecular meshwork," write Shlomo Melamed, MD, and colleagues from the Goldschleger Eye Institute, Sheba Medical Center, in Tel Hashomer, Israel."Clinical results have shown the treatment to be effective and safe in patients with primary open-angle glaucoma and in patients treated previously with ALT."

Goldschleger眼科学校的Shlomo Melamed博士表示，评估SLT的组织学研究显示，小梁成型术与氩雷射不同的是，它不会造成小梁组织网结疤，临床的研究结果显示，对于开放性青光眼初期患者及之前以ALT治疗的患者而言，小梁成型术是有效且安全的治疗方式。

Ann G. Carmichael, MD, PhD, maintains that the bubonic bacillus, Yersinia pestis, was most certainly a factor in the outbreak of plague, but, at the same time, the fearsome reputation of the Black Death may have hidden or deemphasized the emergence of other interacting epidemics such as smallpox, influenza, anthrax, typhus, meningococcemia, mycosis, and acute diarrheal diseases.

医学博士安妮·G·喀米舍尔认为，耶尔森氏菌最有可能是瘟疫爆发的一个因素，但是黑死病令人胆颤的大名可能使得其他一些相互影响的传染病被人们所忽视，比如天花、流行性感冒、炭疽、斑疹伤寒症、脑膜炎球菌血症、真菌病以及急性腹泻等等。

For Clark Haskins, MD, from New Mexico Oncology Hematology Consultants, Ltd, New Mexico Cancer Center, the data do not support the researchers' positive conclusions."The results were crummy," he told Medscape when asked what he thought of the strategy of using metronomic chemotherapy in advanced disease."The problem is that there are a lot of patients who don't want to take chemotherapy, so this strategy is trying to reach these patients," he said."Unfortunately, the data don't support that the strategy works."

新墨西哥癌症中心新墨西哥肿瘤血液肿瘤谘询家Clark Haskins医师表示，这项试验数据并不支持研究者的正面结论；当他被问到有关使用节律性化学疗法在进展性癌症病患的意见时，他向Medscape表示，这项试验结果并不显著，问题在於许多病患不想接受化学疗法，所以这项使用低剂量、持续使用的策略希望可以用在这些病患身上；但不幸的，这项试验的数据并不支持这样的做法是有效的。

For Clark Haskins, MD, from New Mexico Oncology Hematology Consultants, Ltd, New Mexico Cancer Center, the data do not support the researchers' positive conclusions."The results were crummy," he told Medscape when asked what he thought of the strategy of using metronomic chemotherapy in advanced disease."The problem is that there are a lot of patients who don't want to take chemotherapy, so this strategy is trying to reach these patients," he said."Unfortunately, the data don't support that the strategy works."

新墨西哥癌症中心新墨西哥肿瘤血液肿瘤咨询家Clark Haskins医师表示，这项试验数据并不支持研究者的正面结论；当他被问到有关使用节律性化学疗法在进展性癌症病患的意见时，他向Medscape表示，这项试验结果并不显著，问题在于许多病患不想接受化学疗法，所以这项使用低剂量、持续使用的策略希望可以用在这些病患身上；但不幸的，这项试验的数据并不支持这样的做法是有效的。

Burstein, MD, PhD, from the Dana-Farber Cancer Institute and Harvard Cancer Center in Boston, Massachusetts, reported phase 2 results of a trial that randomized 62 women with stage IV breast cancer to metronomic chemotherapy (oral cyclophosphamide 50 mg/d once daily and oral methotrexate 2.5 mg twice daily on days 1 and 2 each week) with or without intravenous bevacizumab (10 mg/kg every 14 days).

Burstein医师报告一项第2期临床试验结果，这项临床试验收纳了62位第4期乳癌接受节律性化学治疗（在每周的第一、二天口服cyclophosphamide每天50毫克，以及口服methotrexate 2.5毫克每天两次），加上或是不加上bevacizumab（10毫克公斤，共14天）；「节律性」疗程被定义为使用低剂量、重复投予的化学疗法。

MD Michiel Hofstee coming in to replace Jennifer Jan.

总经理一职，接替去年年终离职的Jennifer Jan。

An MoIT /PSEB delegation comprising Secretary IT, MD PSEB and Director Marketing PSEB undertook a visit to Texas, New York and California – holding meetings with the Governor of Texas, senior Government officials, and industry leaders.

一个 moit / PSEB代表团，其中包括司，海事处PSEB主任营销PSEB答应访问德克萨斯州，纽约和加利福尼亚州-举行会议，与总督的得克萨斯州，政府高级官员，工商领袖。

Morgenstern, MD, from the University of Michigan Health System in Ann Arbor, suggest that rFVIIa "offers new hope for targeted therapy." However, they caution that the results "should be viewed as preliminary" and are "important but not clinically directive" because of the risk of arterial thromboembolic complications.

Morgenstern医师表示，rFVIIa带来了标的治疗的新希望；然而，他们认为应该将这项试验结果视为是早期，且是重要的，但是因为其所带来的动脉血栓栓塞并发症，这项用法还不是临床导向的。

Myotonic MD's age at onset: 20 to 40 years Myotonic muscular dystrophy is the most common adult form of muscular dystrophy.

强直性海事处发病年龄：从20到40岁强直性肌营养不良症是最常见的成人形式的肌肉萎缩症。

The split between the two groups can hardly be papered over.

这两个团体间的分歧难以掩饰。

This approach not only encourages a greater number of responses, but minimizes the likelihood of stale groupthink.

这种做法不仅鼓励了更多的反应，而且减少跟风的可能性。